Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 50,266,340 | 47,821,850 | 46,347,940 | 42,686,610 | 42,146,720 |
| Cost of Goods | 15,407,620 | 14,429,050 | 14,498,890 | 13,886,940 | 13,413,120 |
| Gross Profit | 34,858,720 | 33,392,800 | 31,849,050 | 28,799,670 | 28,733,600 |
| Operating Expenses | 25,265,840 | 22,672,470 | 22,004,180 | 12,412,030 | 21,463,800 |
| Operating Income | 9,593,504 | 10,720,380 | 9,845,758 | 16,388,580 | 7,269,914 |
| Interest Expense | 1,421,060 | 463,584 | 435,381 | 445,497 | 497,280 |
| Other Income | -555,217 | 795,469 | -138,423 | 235,313 | -3,326,394 |
| Pre-tax Income | 7,617,228 | 11,052,265 | 9,271,954 | 16,178,396 | 3,446,240 |
| Income Tax | 1,733,845 | 2,113,521 | 1,843,270 | 2,070,990 | 155,680 |
| Net Income Continuous | 5,883,383 | 8,938,742 | 7,428,685 | 14,107,410 | 3,290,560 |
| Minority Interests | 38,963 | 119,057 | 66,254 | 41,123 | 34,720 |
| Net Income | $5,844,420 | $8,819,686 | $7,362,432 | $14,066,280 | $3,255,840 |
| EPS Basic Total Ops | 2.33 | 3.52 | 2.94 | 5.61 | 1.25 |
| EPS Basic Continuous Ops | 2.35 | 3.57 | 2.97 | 5.63 | 1.32 |
| EPS Diluted Total Ops | 2.33 | 3.51 | 2.93 | 5.58 | 1.25 |
| EPS Diluted Continuous Ops | 2.34 | 3.56 | 2.95 | 5.60 | 1.31 |
| EPS Diluted Before Non-Recurring Items | 4.39 | 4.35 | 3.88 | 3.35 | 3.32 |
| EBITDA(a) | $14,779,890 | $14,323,690 | $13,810,330 | $20,596,810 | $15,616,150 |